Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

HIV Infection

Free Subscription 18.08.2025 5 AIDS 1 Cancer 6 Clin Infect Dis 1 HIV Med 6 J Acquir Immune Defic Syndr 3 J Immunol 4 J Infect Dis 1 J Med Virol 5 PLoS One 1 PLoS Pathog 2 Proc Natl Acad Sci U S A 1 Science 3 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. HAN WM, Wu K, Tassiopoulos K, Knowles K, et al
   Inflammation in frailty, cognitive impairment, clinical events and mortality among older adults with HIV in the ACTG HAILO cohort.
   AIDS. 2025 Aug 14. doi: 10.1097/QAD.0000000000004324.
   PubMed         Abstract available
   
   
2. INZAULE S, Silva R, Ford N, Thwin SS, et al
   Comparative analyses of COVID-19 in-hospital mortality in people living with HIV during SARS-CoV-2 pre-delta, delta, and omicron waves: data from the who global clinical platform.
   AIDS. 2025 Aug 14. doi: 10.1097/QAD.0000000000004323.
   PubMed         Abstract available
   
   
3. CALCAGNO A, Carola L, Barbara R, Marco M, et al
   Full reservoirs and poor adherence: two cases of symptomatic HIV cerebrospinal fluid escape with tenofovir alafenamide/emtricitabine/bictegravir.
   AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004320.
   PubMed         Abstract available
   
   
4. DAI M, Chander G, Webel AR, Delaney JA, et al
   Alcohol use disorder, but not current alcohol use is associated with falls among people with HIV in care.
   AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004317.
   PubMed         Abstract available
   
   
5. KARDASHIAN A, Golovaty I, Xia F, Ma Y, et al
   The association of food insecurity with hepatic steatosis in women with and without HIV.
   AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004319.
   PubMed         Abstract available
   
   

   
   Cancer

6. MACDUFFIE E, McCallister C, George J, Monare B, et al
   Assessing the impact of multidisciplinary team gynecological oncology care in Botswana: A potential model for low- and middle-income countries.
   Cancer. 2025;131:e70006.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

7. SCHNYDER JL, Haggenburg S, Garcia Garrido HM, Reiners A, et al
   Long-term immunogenicity and boostability of the 13-valent pneumococcal conjugate vaccine followed by the 23-valent pneumococcal polysaccharide vaccine in adults receiving immunosuppressive therapy and adults living with HIV - 3-year follow-up of a pr
   Clin Infect Dis. 2025 Aug 6:ciaf438. doi: 10.1093.
   PubMed         Abstract available
   
   
8. RON R, Diaz-Garcia C, Sendagorta E, Cabello-Ubeda A, et al
   A Phase IV, open-label, single-arm, multicentric clinical trial for evaluation of Human Papillomavirus 9vHPV vaccine immunogenicity in Men Who Have Sex with Men living with HIV: GeSIDA Study 10017.
   Clin Infect Dis. 2025 Aug 6:ciaf435. doi: 10.1093.
   PubMed         Abstract available
   
   
9. RUTAKINGIRWA MK, Skipper CP, Dai B, Wele A, et al
   Evaluating the Use of Lower Dose Flucytosine for the Treatment of Cryptococcal Meningitis: A Clinical Trial.
   Clin Infect Dis. 2025 Aug 7:ciaf432. doi: 10.1093.
   PubMed         Abstract available
   
   
10. NUTT CT, Lessells RJ, Muyindike WR, Johnson LS, et al
    Approaches to the Management of Virologic Failure on Dolutegravir-Based Antiretroviral Therapy in the 50 Countries with the Highest Adult HIV Prevalence.
    Clin Infect Dis. 2025 Aug 11:ciaf444. doi: 10.1093.
    PubMed         Abstract available
    
    
11. PARIENTI JJ
    Background HIV Incidence in PURPOSE 1 and 2 PrEP trials.
    Clin Infect Dis. 2025 Aug 14:ciaf436. doi: 10.1093.
    PubMed         Abstract available
    
    
12. DAVIS JM, Green E, Solomon DA
    A Blurry Line: Navigating Treatment Decisions When the Guidelines Don't Fit.
    Clin Infect Dis. 2025 Aug 14:ciaf396. doi: 10.1093.
    PubMed        
    
    

    
    HIV Med

13. ADACHI E, Minami R, Shirano M, Nakamura H, et al
    Evaluation of cabotegravir plus rilpivirine in routine clinical settings in Japan: A multicentre study of efficacy, safety and biomarker dynamics.
    HIV Med. 2025 Aug 9. doi: 10.1111/hiv.70096.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

14. HAY WONG JM, Balleny R, Lee T, Bitnun A, et al
    Perinatal and early infant outcomes after bictegravir exposure in pregnancy: a Canadian surveillance study.
    J Acquir Immune Defic Syndr. 2025 Aug 14. doi: 10.1097/QAI.0000000000003708.
    PubMed         Abstract available
    
    
15. COMINS CA, Genberg B, Mcingana M, Bandeen-Roche K, et al
    Longitudinal trajectories of engagement with HIV treatment support strategies among female sex workers living with HIV in South Africa.
    J Acquir Immune Defic Syndr. 2025 Aug 14. doi: 10.1097/QAI.0000000000003738.
    PubMed         Abstract available
    
    
16. COONEY EE, Reisner SL, Poteat TC, Althoff KN, et al
    Brief Report: Interest in Long-acting Injectable PrEP Among Transgender Women in Eastern and Southern United States.
    J Acquir Immune Defic Syndr. 2024;97:19-25.
    PubMed         Abstract available
    
    
17. SIMMS V, Kranzer K, Dziva Chikwari C, Dauya E, et al
    Brief Report: Youth Who Acquired HIV Perinatally Have Poorer Viral Suppression Than Those Who Acquired HIV Later in Life: Findings From a Population Survey in Zimbabwe.
    J Acquir Immune Defic Syndr. 2024;97:1-5.
    PubMed         Abstract available
    
    
18. D'ANTONI ML, Andreatta K, Chang S, Cox S, et al
    Brief Report: HIV-1 Resistance Analysis of Participants With HIV-1 and Hepatitis B Initiating Therapy With Bictegravir/Emtricitabine/Tenofovir Alafenamide or Dolutegravir Plus Emtricitabine/Tenofovir Disoproxil Fumarate: A Subanalysis of ALLIANCE Data
    J Acquir Immune Defic Syndr. 2024;96:380-384.
    PubMed         Abstract available
    
    
19. PHOGOLE CM, Bekker A, Cressey TR, Ferris W, et al
    Brief Report: Can a Fraction of the Dolutegravir Dispersible Tablet Solution be Used to Dose Neonates?
    J Acquir Immune Defic Syndr. 2024;96:376-379.
    PubMed         Abstract available
    
    

    
    J Immunol

20. TRAM TTB, Garner LC, Thai LNH, Nhat LTH, et al
    Single-cell profiling of blood and cerebrospinal fluid in tuberculous meningitis.
    J Immunol. 2025 Aug 8:vkaf186. doi: 10.1093.
    PubMed         Abstract available
    
    
21. WROBELN A, Martin Schaper T, Schild Y, Kleine-Mollhoff L, et al
    Roxadustat enhances inflammation and metabolic reprogramming in human leukocytes by affecting oxygen sensing.
    J Immunol. 2025 Aug 12:vkaf167. doi: 10.1093.
    PubMed         Abstract available
    
    
22. PUMTANG-ON P, Thron LK, Goodarzi N, Davey BC, et al
    Humanized DRAGA mice are a valuable model to study novel immunotherapies for HIV-1.
    J Immunol. 2025 Aug 13:vkaf185. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Infect Dis

23. GAO Q, Lan X, Yang F, Yu H, et al
    Prognostic Divergence in HIV/HBV vs. HBV- Associated HCC after Resection: Intrahepatic Pre-S Deletions Mutants and T-cell Depletion under Viral Suppression.
    J Infect Dis. 2025 Aug 14:jiaf433. doi: 10.1093.
    PubMed         Abstract available
    
    
24. NDHLOVU LC, Giron LB, Galinskas J, Premeaux TA, et al
    Virological and Immunological Outcomes of Combined Therapeutic Interventions and Dendritic Cell Therapy in People Living with HIV.
    J Infect Dis. 2025 Aug 14:jiaf430. doi: 10.1093.
    PubMed         Abstract available
    
    
25. PATEL SM, Farirai J, Patel MZ, Boiditswe S, et al
    Alterations of the upper respiratory microbiome among children living with HIV infection in Botswana.
    J Infect Dis. 2025 Aug 12:jiaf429. doi: 10.1093.
    PubMed         Abstract available
    
    
26. GIANELLA S, Taylor J, Shelton B, Martinez N, et al
    Every Body Has Value: Ending Discriminatory Restrictions on Anatomical Donations.
    J Infect Dis. 2025 Aug 6:jiaf413. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

27. CHEN SC, Lee YT
    Reframing HIV Diagnostic Delay: Silent Risk Indicators and Structural Gaps in Australia's Evolving Epidemic.
    J Med Virol. 2025;97:e70555.
    PubMed        
    
    

    
    PLoS One

28. AMADI JA, Odwe G, Obare F, Sambai B, et al
    Interventions addressing impacts of climate change on sexual and reproductive health and rights in sub-Saharan Africa: A scoping review.
    PLoS One. 2025;20:e0329201.
    PubMed         Abstract available
    
    
29. ZOTOVA N, Munyaneza A, Murenzi G, Kubwimana G, et al
    Low birth weight and adverse pregnancy outcomes among women living with HIV and HIV-uninfected in Rwanda.
    PLoS One. 2025;20:e0329312.
    PubMed         Abstract available
    
    
30. META-DJOMSI D, Atsama-Amougou M, Ngamaleu MR, Godwe C, et al
    Molecular surveillance of hepatitis E virus in wastewater in Yaounde, Cameroon.
    PLoS One. 2025;20:e0322765.
    PubMed         Abstract available
    
    
31. WHITE TM, Fuster-RuizdeApodaca MJ, Iniesta C, Prats-Silvestre C, et al
    Challenges and opportunities in monitoring the long-term well-being of people with HIV in Spain.
    PLoS One. 2025;20:e0325355.
    PubMed         Abstract available
    
    
32. MUCHINTA E, Chabala FW
    Chronic kidney disease among HIV-positive Zambian adults with tenofovir-associated nephrotoxicity at University Teaching Hospital (UTH) in Lusaka.
    PLoS One. 2025;20:e0330356.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

33. ZEEB M, Kusejko K, Hartnack S, Pasin C, et al
    Infection with Mycobacterium tuberculosis alters the antibody response to HIV-1.
    PLoS Pathog. 2025;21:e1013350.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

34. LIN X, Cottrell CA, Kalyuzhniy O, Tingle R, et al
    Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial.
    Proc Natl Acad Sci U S A. 2025;122:e2510163122.
    PubMed         Abstract available
    
    
35. PAMPENA MB, Samer S, Viox EG, Nguyen K, et al
    Therapeutic CD8(+) T cell tissue retention and immunomodulation during ART interruption fail to prevent SIV rebound.
    Proc Natl Acad Sci U S A. 2025;122:e2501037122.
    PubMed         Abstract available
    
    

    
    Science

36. COHEN J
    NIH weighs controversial overhaul of HIV budget.
    Science. 2025;389:668-669.
    PubMed         Abstract available
    
    

    
    Vaccine

37. KILLANDER MOLLER I, Hedberg P, Wagner P, Sparen P, et al
    Sociodemographic factors influencing SARS-CoV-2 vaccination uptake in people with and without HIV: Insights from a Swedish Nationwide cohort.
    Vaccine. 2025;62:127580.
    PubMed         Abstract available
    
    
38. GAO L, Zhang X, Mo X, Sun Y, et al
    Duration of immunogenicity of four triple doses and four standard doses hepatitis B vaccine in adults infected with human immunodeficiency virus: A one-year follow-up study in China.
    Vaccine. 2025;62:127596.
    PubMed         Abstract available
    
    
39. YAMEY G, Beyrer C
    The dismantling of the U.S. vaccine regulatory framework.
    Vaccine. 2025;62:127557.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.